Lexaria Bioscience Corp. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Accounts Payable and Accrued Liabilities

Accounts Payable and Accrued Liabilities

6 Months Ended

Feb. 28, 2022

Accounts Payable and Accrued Liabilities

11. Accounts Payable and Accrued Liabilities

11.

Accounts Payable and Accrued Liabilities

		February 28,				August 31,
		2022				2021
		$				$
Accounts Payable
Trades payable			60,873				54,668
Sales tax payable			33,244				-
Accrued Liabilities
Corporate tax payable			-				1,055
Trades payable			22,474				45,000
Balance			116,591				100,723